The Next Web
Amsterdam-based scaleup Lumicks has secured €20mn from the European Investment Bank (EIB) to accelerate the discovery of immunotherapy drugs for cancer. The venture debt funding will help Lumicks further develop and market its cell avidity analyser, a machine with the potential to transform the way researchers study and develop treatments for Europe’s second most deadly disease. …
Read More
EU backs Dutch scaleup Lumicks to fast-track discovery of cancer treatments
Sion Geschwindt
02:23
Amsterdam-based scaleup Lumicks has secured €20mn from the European Investment Bank (EIB) to accelerate the discovery of immunotherapy drugs for cancer. The venture debt funding will help Lumicks further develop and market its cell avidity analyser, a machine with the potential to transform the way researchers study and develop treatments for Europe’s second most deadly
